
Dabiten 150mg Capsule
Marketer
Alteus Biogenics Pvt Ltd
Salt Composition
Dabigatran Etexilate (150mg)
Overview Dabiten 150mg Capsule
CardioGuard 150mg capsules function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in the veins of the legs, lungs, heart, and brain. Frequently prescribed for individuals with atrial fibrillation to prevent clot formation, CardioGuard 150mg is also used post-knee or hip replacement surgery to mitigate clot risk. It can be ingested with or without food, but consistent daily timing is advised. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration should only occur under physician supervision to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications, such as a balanced diet, regular exercise, weight management, and smoking cessation, further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects immediately. Other possible side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not recommended while taking CardioGuard 150mg. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.
Primary Ingredients of Dabiten 150mg Capsule
No text was provided to rephrase. Please provide the text you wish to be rewritten.
Uses of Dabiten 150mg Capsule
Managing and averting venous thromboembolism
Major Benefits of Dabiten 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabiten 150mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dabiten 150mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabiten 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabiten 150mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.
How Dabiten 150mg Capsule works:
Xarelto 150mg capsules are a new generation of oral blood thinners. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dabiten 150mg capsules with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabiten 150mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabiten 150mg capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabiten 150mg Capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabiten 150mg capsules, as dose modification may be necessary. Consult a physician before use; Dabiten 150mg capsules are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dabiten 150mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dabiten 150mg Capsule :
Should you forget a Dabiten 150mg Capsule dose, ingest it immediately if still within the same day. However, omit the missed dose if it's less than 6 hours until your next scheduled intake. Never compensate for a missed dose by doubling the subsequent one.
Facts to Know About Dabiten 150mg Capsule
| Label | Value |
|---|---|
| Type of Compound | Benzimiadazole-based compound |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | Thrombin inhibitor for oral administration |
